Hemiplegic Migraine Panel
NY Approved
Test Overview
Clinical Utility
- Molecular confirmation of a clinical diagnosis
- Identification of at-risk family members
- Assist with treatment/ management decisions
- Recurrence risk assessment
Test Details
Genes
ATP1A2, CACNA1A, PRRT2, SCN1A
Conditions
- Hemiplegic migraine
Lab Method
- Deletion/Duplication Analysis
- Next-Gen Sequencing
Ordering Information
Resources
Test Documents
Billing
Targeted Variant Testing